Neurologic Disorders Therapeutics Market

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
Neurologic Disorders Therapeutics Market aims to provide a comprehensive presentation of the global market for Neurologic Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurologic Disorders Therapeutics. Neurologic Disorders Therapeutics Market contains market size and forecasts of Neurologic Disorders Therapeutics in global, including the following market information:
Global Neurologic Disorders Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Neurologic Disorders Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The early diagnosis of neurodegenerative indications is difficult because of their complex nature, fast progression, and lack of effective diagnostic processes. This has encouraged researchers to focus on the development of novel biomarkers that can accurately detect neurodegenerative indications.
We surveyed the Neurologic Disorders Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurologic Disorders Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Neurologic Disorders Therapeutics Market Segment Percentages, by Type, 2022 (%)
Central Nervous System (CNS)
Peripheral Nervous System (PNS)
Global Neurologic Disorders Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Neurologic Disorders Therapeutics Market Segment Percentages, by Application, 2022 (%)
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness
Global Neurologic Disorders Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Neurologic Disorders Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurologic Disorders Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Neurologic Disorders Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen Inc.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurologic Disorders Therapeutics, market overview.
Chapter 2: Global Neurologic Disorders Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Neurologic Disorders Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurologic Disorders Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.